一、招收类型1．硕士学位研究生：具有推荐免试资格的优秀应届本科毕业生攻读硕士学位研究生。2．博士学位研究生：在部分学科和专业招收具有推荐免试资格的优秀应届本科毕业生直接攻读学术学位型博士研究

一、招收类型1．硕士学位研究生：具有推荐免试资格的优秀应届本科毕业生攻读硕士学位研究生。2．博士学位研究生：在部分学科和专业招收具有推荐免试资格的优秀应届本科毕业生直接攻读学术学位型博士研究生

一、招收类型1．硕士学位研究生：具有推荐免试资格的优秀应届本科毕业生攻读硕士学位研究生。2．博士学位研究生：在部分学科和专业招收具有推荐免试资格的优秀应届本科毕业生直接攻读学术学位型博士研究生

一、招收类型1．硕士学位研究生：具有推荐免试资格的优秀应届本科毕业生攻读硕士学位研究生。2．博士学位研究生：在部分学科和专业招收具有推荐免试资格的优秀应届本科毕业生直接攻读学术学位型博士研究生

一、招收类型1．硕士学位研究生：具有推荐免试资格的优秀应届本科毕业生攻读硕士学位研究生。2．博士学位研究生：在部分学科和专业招收具有推荐免试资格的优秀应届本科毕业生直接攻读学术学位型博士研究生

一、招收类型1．硕士学位研究生：具有推荐免试资格的优秀应届本科毕业生攻读硕士学位研究生。2．博士学位研究生：在部分学科和专业招收具有推荐免试资格的优秀应届本科毕业生直接攻读学术学位型博士研究生

一、招收类型1．硕士学位研究生：具有推荐免试资格的优秀应届本科毕业生攻读硕士学位研究生。2．博士学位研究生：在部分学科和专业招收具有推荐免试资格的优秀应届本科毕业生直接攻读学术学位型博士研究生

姓名：马新亮性别：男职称：教授职务：ThomasJefferson大学急诊医学部研究中心主任招生院所：基础医学院招生类型：科学学位(博)科学学位(硕)招生专业：病理学与病理生理学(博)病理学与病理生理学(硕)研究方向名称：心血管疾病的研究电子信箱：xinlm2000@163.com社会任职1.AmericanHeartAssociation成员2.AmericanPhysiologySociety成员3.SocietyforAcademicEmergencyMedicine成员4.NitricOxideSociety成员5.AmericanDiabetesAssociation成员6.NationalInstitutesofHealth成员7.《JournalofCardiothoracic-RenalResearch》编委8.《AmericanJournalofPhysiology:EndocrinologyandMetabolism》编委9.《PathologyandLaboratoryMedicineInternational》编委10.《DiabetesReviewLetters》编委个人简历1.197609-197908:山西医学院学士2.197909-198209:山西医学院硕士3.198602-198807:第四军医大学博士4.198910-199106:美国托马斯?杰佛逊大学生理学系博士后5.199107-199307:美国托马斯?杰佛逊大学生理学系实验室主任6.199307-199707:美国托马斯?杰佛逊大学医学院急诊医学部助理教授7.199707-200207:美国托马斯?杰佛逊大学医学院急诊医学部副教授8.200207-:美国托马斯?杰佛逊大学医学院急诊医学教授9.201005-:首都医科大学生理与病理生理学系教授重要学术论文1.YuQJ,GaoF,MaXL.InsulinsaysNOtocardiovasculardisease..CircRes.2011,89:516-524.SCI2.YuQJ,GaoF,MaXL*..InsulinsaysNOtocardiovasculardisease.Invitedreviewarticle..CardiovascRes.2011,89:516-524.SCI3.CilentiL,BalakrishnanMP,WangXL,AmbiveroC,SterlicchiM,MonteFD,MaXL*,andZervosAS..RegulationofAbro1/KIAA0157ringmyocardialinfarctionandcelldeathrevealsanovelcardioprotectivemechanismforLys63-specificdeubiquitination..JournalofMolecularandCellularCardiology.2011,50(4):652-661.SCI4.YuanY,GaoE,WangY,WangXL,YiW,LauWB,WongW,KochW,MaX*..CTRPs,Anoveltherapeutictargetagainstmyocardialischemia/reperfusioninjury..Circulation.2010,122:A14133.SCI5.LauWB,TaoL,WangYJ,LiR,MAXL.SystemicAdiponectinMalfunctionasaRiskFactorforCardiovascularDisease.Antioxidant&RedoxSignaling.2010,11:21.SCI6.YiW,SunY,GaoEH,WeiXF,LauWB,ZhengQJ,WangYJ,YuanYX,WangXL,TaoL,LiR,KockWJ,MaXL.RecedCardioprotectiveActionofAdiponectininHighFatDietIncedTypeIIDiabeticMiceanditsUnderlyingMechanisms.Antioxidant&RedoxSignaling.2010,11:21.SCI7.177.ChenG,LaiW,LiuF,MaoQ,TuF,WenJ,XiaoH,ZhangJC,ZhuT,ChenB,HuZY,LiRM,LiangZ,NieH,YanH,YangBX,DuQ,HuangWX,JiangYW,KwanAS,SongL,WuCM,XiangT,XuHW,LauWB,SongHB,WenCB,YaoZH,ZhangL,ZengJ,DaiYE,LopezBL,ZhengJQ,ZhouJ,ChristopherTA,MaXL,.Thedragonstrikes:LessonsfromtheWenchuanearthquake.AnesthAnalg.2010,110:908-915.SCI8.173.YuanYX,JiaoXY,LauWB,WangYJ,ChristopherTA,LopezBL,RamachandraRaoSP,TaoL,MaXL.Recedvascularresponsivenesstoadiponectininhyperlipidemicrats-mechanismsandsignificance.JMolCellCardiol.2010,49:508-515.SCI9.WangYJ,LauWB,GaoEH,TaoL,YuanYX,,LiR,WangXL,KockWJ,MaXL*..Cardiomyocyte-DerivedAdiponectinisBiologicallyActiveinProtectingAgainstMyocardialIschemia/ReperfusionInjury..AmJPhysiolEndocrinolMetab.2010,298:E663-670.SCI10.YuanYX,JiaoXY,LauWB,WangYJ,ChristopherTA,LopezBL,RamachandraRaoSP,TaoL,MaXL*..Thioredoxinglycation:Anovelpost-translationalmodificationthatinhibitsitsanti-oxidantandorganprotectiveactions..FreeRadBiolMed.2010,19:332-338.SCI11.TaoL,WangYJ,GaoEH,ZhangHX,YuanYX,LauWB,ChanL,KochWJ,MaXL*..Adiponectin:AnIndispensableMoleculeinRosiglitazoneCardioprotectionFollowingMyocardialInfarction..CircRes.2010,106:409-417.SCI12.YanZ,LiangF,GuoL,WangJ,WangXL,ChengXL,MaXL,LiuHR..Myeloperoxidaseincreasedcardiomyocyteproteinnitrationinmicesubjectedtononlethalmechanicaltrauma..BiochemBiophysResCommun.2010,393:531-535.SCI13.WangXL,LauWB,YuanYX,WangYJ,YiW,ChristopherTA,LopezBL,LiuHR,MaXL*..Methylglyoxalincreasescardiomyocyteischemia/reperfusioninjuryviaglycativeinhibitionofthioredoxinactivity..AmJPhysiolEndocrinolMetab.2010,299:E207-214.SCI14.GaoEH,LeiYH,ShangX,HuangZM,ZuoL,BoucherM,FanQ,ChuprunJK,MaXL,KochWJ..ANovelandEfficientModelofCoronaryArteryLigationandMyocardialInfarctionintheMouse.CircRes.2010,107:1445-1453.SCI15.LiR,LauWB,MaXL*..Adiponectinresistanceandvasculardysfunctioninthehyperlipidemicstate..ActaPharmacologicaSinica.2010,31(10):1258-1266.SCI16.LauWB,TaoL,WangYJ,LiR,MAXL..SystemicAdiponectinMalfunctionasaRiskFactorforCardiovascularDisease.Antioxidant&RedoxSignaling.2010,11:21.SCI17.WangYJ,GaoEH,TaoL,LauWB,YuanYX,GoldsteinBJ,LopezBL,ChristopherTA,TianR,KochW,MaXL*..AMPKDeficiencyEnhancesMyocardialIschemia/ReperfusionInjurybuthasMinimalEffectonAdiponectin’sAnti-Oxidant/Anti-NitrativeProtection..Circulation.2009,119:835-844.SCI18.LiuHR,TaoL,GaoEH,QuY,LopezBL,ChristopherTA,KochW,YueTL,MaXL*..RosiglitazoneInhibitsHypercholesterolemia-IncedMyeloperoxidaseUpregulation-aNovelMechanismfortheCardioprotectiveEffectsofPPARAgonists..CardiovascRes.2009,81:344-352.SCI19.YeMX,WangYM,MaXL,PeiJM..Rosiglitazone,notonlypotentiallyprotectsmyocardiumagainstcomplicationsoftype2diabetesmellitusbutalsoincesmyocardiuminfarction:Possiblemechanisms?.BioscienceHypotheses.2009,2:176-177.SCI20.WangYJ,TaoL,YuanYX,LauWB,LiR,LopezBL,ChristopherTA,TianR,MaXL*..CardioprotectiveEffectofAdiponectinisPartiallyMediatedbyitsAMPK-IndependentAnti-NitrativeAction..AmJPhysiolEndocrinolMetab.2009,297:E384-391.SCI21.JiaoXY,GaoEH,YuanYX,WangYJ,LauWB,KochW,MaXL,TaoL..INO-4885,aNovelPeroxynitriteDecompositionCatalyst,ProtectstheHeartagainstReperfusionInjuryinMice..JPharmExpTher.2009,328:777-784.SCI22.CaoY,TaoL,JiaoXY,LauWB,YuanYX,WangYJ,ChristopherTA,LopezBL,ChanL,GoldsteinBJ,MaXL*..EndothelialDysfunctioninAdiponectinDeficiencyanditsMechanismsInvolved..JMCC.2009,46(3):413-419.SCI23.GoldsteinBJ,ScaliaRG,MaXL*..Protectivevascularandmyocardialeffectsofadiponectin..NatClinPractCardiovascMed.2009,6:27-35.SCI24.LiR,WangWQ,ZhangHF,YangXC,FanQ,ChristopherTA,LopezBL,TaoL,Goldstein,BJ,GaoF,MaXL*..AdiponectinImprovesEndothelialFunctioninHyperlipidemicRatsbyRecingOxidative/NitrativeStressandDifferentialRegulationofeNOS/iNOSActivity..AmJPhysiolEndocrinolMetab.2007,293:1703-1708.SCI25.WangXL,LiuHR,TaoL,LiangF,YanL,ZhaoRR,LopezBL,ChristopherTA,MaXL*..RoleofiNOS-DerivedReactiveNitrogenSpeciesandResultantNitrativeStressinLeukocytes-IncedCardiomyocyteApoptosisafterMyocardialIschemia/Reperfusion..Apoptosis.2007,12:1209-1217.SCI26.LiSZ,TaoL,JiaoXY,LiuHR,CaoY,LopezBL,LuanRH,ChristopherTA,MaXL*..TNFα-InitiatedOxidative/NitrativeStressMediatesCardiomyocyteApoptosisinTraumaticAnimals..Apoptosis.2007,12:1795-1802.SCI27.ZhangHX,TaoL,GaoEH,JiaoXY,LopezBL,ChristopherTA,KochWJ,MaXL*..NitrativeThioredoxinInactivationasaCauseofEnhancedMyocardialIschemia/ReperfusionInjuryintheAgingHeart.FreeRadicalBiologyandMedicine.2007,43:39-47.SCI28.TaoL,GaoER,JiaoXY,ChristopherTA,LopezBL,KochWJ,ChanL,GoldsteinB,MaXL*..AdiponectinCardioprotectionAfterMyocardialIschemia/ReperfusionInvolvestheRectionofOxidative/NitrativeStress.Circulation.2007,115:1408-1416.SCI主编或副主编的著作/译著重要奖项1.AmericanHeartAssociationResearchExcellenceAward2008072.AmericanCollegeofEmergencyPhysicianEstablishedInvestigatorAward2002033.WhoisWhoinAmerican,56thEdition.200109

一、招收类型1．硕士学位研究生：具有推荐免试资格的优秀应届本科毕业生攻读硕士学位研究生。2．博士学位研究生：在部分学科和专业招收具有推荐免试资格的优秀应届本科毕业生直接攻读学术学位型博士研究生